ArticleOncotarget2017

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.

Amanda Tivnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.